[
THE INVESTOR] As of Oct. 27 11:25 A.M., Boryung Pharmaceutical declined 5.42%, compared with yesterday, to 39,300 won. It had edged along with a similar price through the past month. Standard deviation, which indicates risk, records 1.7% over the same period over one month.
Compared with its close competitors within the same industry, KOSPI, as the monthly volatility of Boryung Pharmaceutical was at a low level, the earnings rate for 1 month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 0.1%. Even though the volatility was not so high, the return-on-risk was low through a decline in investment returns. Moreover, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 5.6, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (
hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.